The purpose of this study is to determine whether a consultation with a Personalized Therapeutics Clinic, or PTC, will help participants lower the risk for sid…

CancerAdvanced CancerAdvanced Solid Tumor+2 more

~Estimated

~$10 – $6,250

University of ChicagoNCT05166694

Phase 1

A Phase Ia/Ib, Open-Label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of BC3195 in Patients With Locally Advanced or Metastatic Solid Tumors

This is a phase Ia/Ib, open-label, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of B…

Advanced CancerMetastatic Solid Tumor

~Estimated

~$10 – $8,750

Biocity Biopharmaceutics Co., Ltd.NCT06548672

← PreviousPage 6 of 6Next →